Barclays’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Sell |
1,019,565
-330,198
| -24% | -$644K | ﹤0.01% | 2232 |
|
|
2025
Q1 | $2.38M | Buy |
1,349,763
+70,051
| +5% | +$123K | ﹤0.01% | 1913 |
|
|
2024
Q4 | $3.4M | Buy |
1,279,712
+61,391
| +5% | +$163K | ﹤0.01% | 1856 |
|
|
2024
Q3 | $2.79M | Sell |
1,218,321
-333,817
| -22% | -$764K | ﹤0.01% | 1941 |
|
|
2024
Q2 | $4.53M | Sell |
1,552,138
-53,568
| -3% | -$156K | ﹤0.01% | 1238 |
|
|
2024
Q1 | $5.84M | Buy |
1,605,706
+1,118,954
| +230% | +$4.07M | ﹤0.01% | 1296 |
|
|
2023
Q4 | $735K | Buy |
486,752
+384,443
| +376% | +$581K | ﹤0.01% | 2792 |
|
|
2023
Q3 | $137K | Sell |
102,309
-2,845
| -3% | -$3.81K | ﹤0.01% | 3199 |
|
|
2023
Q2 | $190K | Sell |
105,154
-119,324
| -53% | -$216K | ﹤0.01% | 3112 |
|
|
2023
Q1 | $371K | Buy |
224,478
+156,016
| +228% | +$258K | ﹤0.01% | 2832 |
|
|
2022
Q4 | $132K | Buy |
68,462
+11,909
| +21% | +$23K | ﹤0.01% | 3307 |
|
|
2022
Q3 | $127K | Buy |
56,553
+3,377
| +6% | +$7.58K | ﹤0.01% | 3307 |
|
|
2022
Q2 | $172K | Sell |
53,176
-7,746
| -13% | -$25.1K | ﹤0.01% | 3221 |
|
|
2022
Q1 | $321K | Buy |
+60,922
| New | +$321K | ﹤0.01% | 3065 |
|